Verve Therapeutics News

Verve Therapeutics | ARS: Annual Report to Security Holders

Apr 26 08:03 ET

Verve Therapeutics | DEFA14A: Others

Apr 26 07:58 ET

Verve Therapeutics | DEF 14A: Definitive information statements

Apr 26 07:33 ET

Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nickerson Joan

Apr 3 17:05 ET

Verve Therapeutics | 8-K: Current report

Apr 2 07:14 ET

Verve Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 08:35 ET

Verve Therapeutics | 10-K: Annual report

Feb 27 08:05 ET

Verve Therapeutics | 8-K: Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 27 07:50 ET

Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ashe Andrew D.

Feb 16 16:34 ET

Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kathiresan Sekar

Feb 16 16:32 ET

Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nickerson Joan

Feb 16 16:32 ET

Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fiedorek Fred T.

Feb 16 16:32 ET

Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dorval Allison

Feb 16 16:32 ET

Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bellinger Andrew

Feb 16 16:32 ET

Verve Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.81%)

Feb 13 22:30 ET

Verve Therapeutics | 5: Annual statement of changes in beneficial ownership of securities-Director ADELMAN BURT A

Feb 9 17:07 ET

Verve Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)

Jan 29 17:34 ET

Verve Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARK Investment Management LLC(8.74%)

Jan 29 16:04 ET

Verve Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(4.81%)

Jan 23 00:00 ET

Verve Therapeutics | SCHEDULE 13G/A: Others

Jan 16 00:00 ET